Sarra Boudriga

751 total citations
25 papers, 608 citations indexed

About

Sarra Boudriga is a scholar working on Organic Chemistry, Pharmaceutical Science and Toxicology. According to data from OpenAlex, Sarra Boudriga has authored 25 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 4 papers in Pharmaceutical Science and 4 papers in Toxicology. Recurrent topics in Sarra Boudriga's work include Synthesis and biological activity (10 papers), Organic Chemistry Cycloaddition Reactions (6 papers) and Asymmetric Synthesis and Catalysis (5 papers). Sarra Boudriga is often cited by papers focused on Synthesis and biological activity (10 papers), Organic Chemistry Cycloaddition Reactions (6 papers) and Asymmetric Synthesis and Catalysis (5 papers). Sarra Boudriga collaborates with scholars based in Tunisia, France and Germany. Sarra Boudriga's co-authors include Michael Knorr, Carsten Strohmann, Moheddine Askri, Armand Soldera, Yoann Rousselin, Christopher Golz, Lukas Brieger, Khaled Hamden, Marek M. Kubicki and Mansour Sobeh and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Organic Chemistry and Molecules.

In The Last Decade

Sarra Boudriga

23 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarra Boudriga Tunisia 13 557 110 59 51 35 25 608
Y. N. Reddy India 12 461 0.8× 123 1.1× 27 0.5× 47 0.9× 25 0.7× 26 551
Moheddine Askri France 10 426 0.8× 83 0.8× 46 0.8× 37 0.7× 22 0.6× 15 454
Mukund P. Tantak India 14 334 0.6× 172 1.6× 38 0.6× 62 1.2× 27 0.8× 24 440
Penélope Merino‐Montiel Mexico 13 258 0.5× 191 1.7× 123 2.1× 57 1.1× 28 0.8× 33 421
Vinay A. Sunagar India 12 413 0.7× 100 0.9× 23 0.4× 90 1.8× 42 1.2× 31 477
I. G. Rathish India 7 472 0.8× 167 1.5× 39 0.7× 101 2.0× 33 0.9× 9 547
Atukuri Dorababu India 14 428 0.8× 128 1.2× 27 0.5× 54 1.1× 54 1.5× 36 545
Gopala Reddy Palnati India 13 415 0.7× 138 1.3× 33 0.6× 87 1.7× 38 1.1× 17 520
Sara Montiel‐Smith Mexico 13 225 0.4× 243 2.2× 81 1.4× 59 1.2× 22 0.6× 44 453
Santanu Hati India 13 309 0.6× 156 1.4× 30 0.5× 49 1.0× 17 0.5× 18 439

Countries citing papers authored by Sarra Boudriga

Since Specialization
Citations

This map shows the geographic impact of Sarra Boudriga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarra Boudriga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarra Boudriga more than expected).

Fields of papers citing papers by Sarra Boudriga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarra Boudriga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarra Boudriga. The network helps show where Sarra Boudriga may publish in the future.

Co-authorship network of co-authors of Sarra Boudriga

This figure shows the co-authorship network connecting the top 25 collaborators of Sarra Boudriga. A scholar is included among the top collaborators of Sarra Boudriga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarra Boudriga. Sarra Boudriga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El-Sofany, Walaa I., Ismail Daoud, Salman Latif, et al.. (2025). Novel triazole-tethered thiazol-4(5H)-one hybrids as potential therapeutics for obesity and type 2 diabetes: in vitro, in vivo, and in silico evaluations. Journal of Molecular Structure. 1341. 142577–142577.
3.
Jourdain, Isabelle, et al.. (2024). Synthesis of (Z)-3-Allyl-5-(4-nitrobenzylidene)-2-sulfanylidene-1,3-thiazolidin-4-one and Determination of Its Crystal Structure. SHILAP Revista de lepidopterología. 2024(1). M1783–M1783. 2 indexed citations
7.
Boudriga, Sarra, Khaled Hamden, Moheddine Askri, et al.. (2022). New spiropyrrolothiazole derivatives bearing an oxazolone moiety as potential antidiabetic agent: Design, synthesis, crystal structure, Hirshfeld surface analysis, ADME and molecular docking studies. Journal of Molecular Structure. 1254. 132398–132398. 18 indexed citations
9.
Boudriga, Sarra, Michael Knorr, Emmanuel Roulland, et al.. (2021). Antimicrobial Activity and In Silico Molecular Docking Studies of Pentacyclic Spiro[oxindole-2,3′-pyrrolidines] Tethered with Succinimide Scaffolds. Applied Sciences. 12(1). 360–360. 18 indexed citations
10.
Boudriga, Sarra, Khaled Hamden, Mansour Sobeh, et al.. (2020). Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors. Bioorganic Chemistry. 106. 104507–104507. 97 indexed citations
11.
Boudriga, Sarra, Vikneswaran Murugaiyah, Moheddine Askri, et al.. (2020). Three-Component Access to Functionalized Spiropyrrolidine Heterocyclic Scaffolds and Their Cholinesterase Inhibitory Activity. Molecules. 25(8). 1963–1963. 28 indexed citations
13.
Boudriga, Sarra, Moheddine Askri, Abderrahim Khatyr, et al.. (2016). Stoichiometry-controlled cycloaddition of nitrilimines with unsymmetrical exocyclic dienones: microwave-assisted synthesis of novel mono- and dispiropyrazoline derivatives. RSC Advances. 6(55). 49868–49875. 17 indexed citations
14.
Boudriga, Sarra, Moheddine Askri, Michael Knorr, et al.. (2015). Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents. Bioorganic & Medicinal Chemistry Letters. 25(19). 4308–4313. 38 indexed citations
15.
Boudriga, Sarra, Moheddine Askri, Michael Knorr, et al.. (2015). Synthesis of highly substituted spiropyrrolidines via 1, 3-dipolar cycloaddition reaction of N-metalated azomethine ylides. A new access to spiropyrrolines derivatives. Mediterranean Journal of Chemistry. 4(1). 30–50. 4 indexed citations
16.
Boudriga, Sarra, Tarunkumar Nanjibhai Akhaja, Jignesh P. Raval, et al.. (2014). A strategic approach to the synthesis of functionalized spirooxindole pyrrolidine derivatives: in vitro antibacterial, antifungal, antimalarial and antitubercular studies. New Journal of Chemistry. 39(1). 520–528. 112 indexed citations
17.
Boudriga, Sarra, Armand Soldera, Dharmarajan Sriram, et al.. (2014). Synthesis of novel dispiropyrrolothiazoles by three-component 1,3-dipolar cycloaddition and evaluation of their antimycobacterial activity. RSC Advances. 4(103). 59462–59471. 35 indexed citations
18.
Rammah, Mohamed M., Sarra Boudriga, Michael Knorr, et al.. (2010). Regio- and Stereoselective 1,3-Dipolar Cycloaddition of C-Aryl-N-phenylnitrones over (E)-Arylidene-(2H)-indan-1-ones: Synthesis of Highly Substituted Novel Spiro-isoxazolidines. Heterocycles. 81(12). 2749–2749. 8 indexed citations
20.
Boudriga, Sarra, et al.. (2003). 1,3-Dipolar cycloadditions of Arylcarbonitrile Oxides and Diaryl Nitrilimines with Some 2-Arylmethylene-1,3-Indanediones; regiochemistry of the Reactions. Journal of Chemical Research. 2003(4). 204–207. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026